Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population

Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

(2020) Ami D. Sperber et al.   GASTROENTEROLOGY

Health Care Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States

(2020) Irene B. Murimi et al.   JOURNAL OF RHEUMATOLOGY

Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance – the perspective of private and public payers

(2020) Nirmish R. Shah et al.   JOURNAL OF MEDICAL ECONOMICS

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries

(2020) Melissa J. Barber et al.   Journal of Virus Eradication

Medicaid spending burden among beneficiaries with treatment-resistant depression

(2019) Dominic Pilon et al.   Journal of Comparative Effectiveness Research

Burden and Cost of Outpatient Hemorrhoids in the United States Employer-Insured Population, 2014

(2019) Jeff Y. Yang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation

(2019) K T Park et al.   INFLAMMATORY BOWEL DISEASES

Lifetime Economic Burden of Crohn’s Disease and Ulcerative Colitis by Age at Diagnosis

(2019) Gary R. Lichtenstein et al.   Clinical Gastroenterology and Hepatology

Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms

(2019) Sean D. Delshad et al.   GASTROENTEROLOGY

Economic Costs of Diabetes in the U.S. in 2017

(2018)   DIABETES CARE

Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data from a Large US Claims Database

(2018) Alina M. Allen et al.   HEPATOLOGY

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018

(2018) Anne F. Peery et al.   GASTROENTEROLOGY

Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population

(2017) Jessica L. Buono et al.   Journal of Managed Care & Specialty Pharmacy

All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States

(2016) Carl V. Asche et al.   JOURNAL OF MANAGED CARE PHARMACY

All-Cause and Incremental Per Patient Per Year Cost Associated with Chronic Hepatitis C Virus and Associated Liver Complications in the United States: A Managed Care Perspective

(2016) Carrie McAdam-Marx et al.   JOURNAL OF MANAGED CARE PHARMACY

Economic Burden of Irritable Bowel Syndrome with Constipation: A Retrospective Analysis of Health Care Costs in a Commercially Insured Population

(2016) Jalpa A. Doshi et al.   JOURNAL OF MANAGED CARE PHARMACY

Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States

(2015) Anne F. Peery et al.   GASTROENTEROLOGY

Clinical and Economic Burden of Emergency Department Visits Due to Gastrointestinal Diseases in the United States

(2013) Parvathi A Myer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population

(2013) Qian Cai et al.   JOURNAL OF MEDICAL ECONOMICS

Burden of Gastrointestinal Disease in the United States: 2012 Update

(2012) Anne F. Peery et al.   GASTROENTEROLOGY

The economics of upper gastrointestinal bleeding in a US managed-care setting: a retrospective, claims-based analysis

(2010) B. L. Cryer et al.   JOURNAL OF MEDICAL ECONOMICS

Burden of Digestive Diseases in the United States Part II: Lower Gastrointestinal Diseases

(2009) James E. Everhart et al.   GASTROENTEROLOGY

Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal Diseases

(2009) James E. Everhart et al.   GASTROENTEROLOGY